| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Integrins | 12 | 2009 | 88 | 1.570 |
Why?
|
| Integrin alpha4beta1 | 9 | 2018 | 26 | 1.090 |
Why?
|
| Integrin beta Chains | 4 | 2021 | 9 | 1.050 |
Why?
|
| Leukocytes | 2 | 2021 | 202 | 0.870 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2021 | 288 | 0.800 |
Why?
|
| Syk Kinase | 3 | 2021 | 17 | 0.780 |
Why?
|
| Cefsulodin | 1 | 2021 | 1 | 0.690 |
Why?
|
| Ceftazidime | 1 | 2021 | 46 | 0.650 |
Why?
|
| T-Lymphocytes | 13 | 2022 | 1705 | 0.560 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2018 | 144 | 0.500 |
Why?
|
| Cell Adhesion | 10 | 2013 | 299 | 0.450 |
Why?
|
| Scavenger Receptors, Class E | 1 | 2014 | 8 | 0.440 |
Why?
|
| Chaperonin Containing TCP-1 | 1 | 2014 | 9 | 0.440 |
Why?
|
| Protein-Tyrosine Kinases | 4 | 2003 | 220 | 0.430 |
Why?
|
| Lymphocyte Activation | 9 | 2010 | 669 | 0.420 |
Why?
|
| Myosin Light Chains | 2 | 2012 | 14 | 0.380 |
Why?
|
| Enzyme Precursors | 2 | 2002 | 23 | 0.380 |
Why?
|
| Antigens, CD | 6 | 2012 | 415 | 0.360 |
Why?
|
| Thy-1 Antigens | 1 | 2011 | 20 | 0.360 |
Why?
|
| Multipotent Stem Cells | 1 | 2011 | 21 | 0.360 |
Why?
|
| Protein Binding | 9 | 2021 | 1661 | 0.340 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 6 | 2013 | 68 | 0.340 |
Why?
|
| Antibodies, Bispecific | 1 | 2011 | 49 | 0.330 |
Why?
|
| Hydrogels | 2 | 2022 | 94 | 0.330 |
Why?
|
| Stromal Cells | 1 | 2011 | 301 | 0.310 |
Why?
|
| Selectins | 2 | 2008 | 4 | 0.290 |
Why?
|
| Molecular Targeted Therapy | 1 | 2011 | 380 | 0.290 |
Why?
|
| Nanofibers | 2 | 2019 | 15 | 0.280 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2008 | 56 | 0.280 |
Why?
|
| Phosphoproteins | 4 | 2003 | 420 | 0.270 |
Why?
|
| T-Lymphocyte Subsets | 2 | 1999 | 199 | 0.270 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2021 | 132 | 0.270 |
Why?
|
| Immunologic Memory | 2 | 1999 | 194 | 0.270 |
Why?
|
| Interleukin-2 | 5 | 1999 | 234 | 0.250 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 4 | 2016 | 95 | 0.250 |
Why?
|
| CD3 Complex | 4 | 2000 | 91 | 0.250 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2018 | 3693 | 0.250 |
Why?
|
| Models, Molecular | 3 | 2018 | 1057 | 0.240 |
Why?
|
| Hindlimb | 2 | 2016 | 73 | 0.240 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 2 | 2022 | 26 | 0.240 |
Why?
|
| Cell Movement | 6 | 2013 | 849 | 0.240 |
Why?
|
| Phosphorylation | 6 | 2021 | 1536 | 0.240 |
Why?
|
| Inflammation Mediators | 1 | 2006 | 222 | 0.230 |
Why?
|
| Amino Acid Sequence | 5 | 2014 | 2541 | 0.230 |
Why?
|
| Ligands | 2 | 2018 | 477 | 0.220 |
Why?
|
| Signal Transduction | 10 | 2021 | 4472 | 0.220 |
Why?
|
| GTP-Binding Proteins | 2 | 2002 | 160 | 0.210 |
Why?
|
| Myocardial Infarction | 1 | 2011 | 980 | 0.210 |
Why?
|
| Animals | 19 | 2024 | 33045 | 0.210 |
Why?
|
| Phosphotyrosine | 2 | 2003 | 30 | 0.200 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2008 | 622 | 0.200 |
Why?
|
| Peptides | 5 | 2022 | 828 | 0.200 |
Why?
|
| Inflammation | 2 | 2010 | 1420 | 0.200 |
Why?
|
| Lipoprotein(a) | 1 | 2024 | 133 | 0.200 |
Why?
|
| Asthma | 2 | 2008 | 764 | 0.190 |
Why?
|
| Ischemia | 2 | 2016 | 343 | 0.190 |
Why?
|
| Integrin beta1 | 3 | 1998 | 54 | 0.190 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2003 | 68 | 0.190 |
Why?
|
| Immunity, Humoral | 1 | 2022 | 73 | 0.190 |
Why?
|
| Receptor-CD3 Complex, Antigen, T-Cell | 1 | 2001 | 3 | 0.180 |
Why?
|
| Jurkat Cells | 9 | 2013 | 84 | 0.180 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 2001 | 30 | 0.180 |
Why?
|
| Models, Immunological | 1 | 2001 | 36 | 0.180 |
Why?
|
| CD28 Antigens | 2 | 1998 | 74 | 0.180 |
Why?
|
| THP-1 Cells | 1 | 2021 | 21 | 0.170 |
Why?
|
| Botulinum Toxins | 2 | 2003 | 124 | 0.170 |
Why?
|
| High-Throughput Screening Assays | 1 | 2021 | 113 | 0.160 |
Why?
|
| Receptors, Cell Surface | 1 | 2002 | 422 | 0.160 |
Why?
|
| Lipoproteins, LDL | 2 | 2024 | 119 | 0.160 |
Why?
|
| Protein Structure, Tertiary | 5 | 2006 | 718 | 0.160 |
Why?
|
| Small Molecule Libraries | 1 | 2021 | 129 | 0.160 |
Why?
|
| Leukocyte Common Antigens | 1 | 1999 | 83 | 0.150 |
Why?
|
| Carrier Proteins | 2 | 2001 | 1011 | 0.150 |
Why?
|
| Ribose | 1 | 1998 | 11 | 0.150 |
Why?
|
| Transcription Factor AP-1 | 2 | 1998 | 107 | 0.150 |
Why?
|
| Adenosine Diphosphate | 1 | 1998 | 52 | 0.150 |
Why?
|
| Intracellular Fluid | 1 | 1998 | 20 | 0.150 |
Why?
|
| Molecular Sequence Data | 3 | 2014 | 3584 | 0.140 |
Why?
|
| Molecular Conformation | 1 | 2018 | 94 | 0.140 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2001 | 576 | 0.140 |
Why?
|
| CHO Cells | 6 | 2003 | 148 | 0.140 |
Why?
|
| GTP Phosphohydrolases | 1 | 1998 | 157 | 0.130 |
Why?
|
| Cell Cycle Proteins | 1 | 2001 | 677 | 0.130 |
Why?
|
| Humans | 33 | 2024 | 126679 | 0.130 |
Why?
|
| Cricetinae | 6 | 2003 | 365 | 0.130 |
Why?
|
| Fibronectins | 3 | 2009 | 99 | 0.130 |
Why?
|
| Liposomes | 1 | 2018 | 196 | 0.130 |
Why?
|
| Antibodies | 1 | 1998 | 351 | 0.130 |
Why?
|
| Cytoskeletal Proteins | 3 | 2003 | 273 | 0.130 |
Why?
|
| Structure-Activity Relationship | 1 | 2018 | 565 | 0.130 |
Why?
|
| Atherosclerosis | 1 | 2024 | 929 | 0.120 |
Why?
|
| Epoprostenol | 1 | 2016 | 42 | 0.120 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2016 | 72 | 0.120 |
Why?
|
| Protein Subunits | 2 | 2014 | 162 | 0.120 |
Why?
|
| Melanoma | 1 | 2022 | 898 | 0.120 |
Why?
|
| Neovascularization, Physiologic | 1 | 2016 | 199 | 0.110 |
Why?
|
| Cytoplasm | 4 | 2003 | 249 | 0.110 |
Why?
|
| Immunosuppressive Agents | 1 | 1998 | 649 | 0.110 |
Why?
|
| Cell Line | 5 | 2016 | 2560 | 0.100 |
Why?
|
| Integrin alpha4 | 4 | 2003 | 11 | 0.100 |
Why?
|
| RNA, Long Noncoding | 1 | 2016 | 228 | 0.100 |
Why?
|
| Heterocyclic Compounds, 4 or More Rings | 1 | 2013 | 34 | 0.100 |
Why?
|
| Solubility | 2 | 2006 | 120 | 0.100 |
Why?
|
| Multiprotein Complexes | 1 | 2014 | 191 | 0.100 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 372 | 0.100 |
Why?
|
| Cattle | 1 | 2014 | 537 | 0.100 |
Why?
|
| Cell Adhesion Molecules | 3 | 2004 | 216 | 0.100 |
Why?
|
| Integrin alpha2beta1 | 1 | 2012 | 8 | 0.100 |
Why?
|
| Adherens Junctions | 1 | 2012 | 15 | 0.100 |
Why?
|
| Kinetics | 2 | 2006 | 1090 | 0.090 |
Why?
|
| ZAP-70 Protein-Tyrosine Kinase | 2 | 2002 | 12 | 0.090 |
Why?
|
| src Homology Domains | 2 | 2002 | 35 | 0.090 |
Why?
|
| RNA, Small Interfering | 1 | 2014 | 658 | 0.090 |
Why?
|
| In Vitro Techniques | 2 | 2006 | 822 | 0.090 |
Why?
|
| Cadherins | 1 | 2012 | 174 | 0.090 |
Why?
|
| Cell Division | 3 | 2003 | 720 | 0.090 |
Why?
|
| ADP Ribose Transferases | 2 | 2003 | 20 | 0.090 |
Why?
|
| rhoA GTP-Binding Protein | 2 | 2003 | 44 | 0.090 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2002 | 578 | 0.080 |
Why?
|
| Mice | 5 | 2022 | 17594 | 0.080 |
Why?
|
| Thiophenes | 1 | 2010 | 68 | 0.080 |
Why?
|
| Binding Sites | 4 | 2006 | 1185 | 0.080 |
Why?
|
| Mice, Knockout | 1 | 2018 | 3709 | 0.080 |
Why?
|
| Bone Marrow Cells | 1 | 2011 | 238 | 0.080 |
Why?
|
| Protein Conformation | 2 | 2010 | 800 | 0.080 |
Why?
|
| Urea | 1 | 2010 | 224 | 0.080 |
Why?
|
| Endothelium, Vascular | 1 | 2012 | 459 | 0.080 |
Why?
|
| G(M1) Ganglioside | 1 | 2009 | 9 | 0.080 |
Why?
|
| Actins | 2 | 2003 | 311 | 0.070 |
Why?
|
| Membrane Microdomains | 1 | 2009 | 60 | 0.070 |
Why?
|
| Stem Cells | 1 | 2013 | 683 | 0.070 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2010 | 293 | 0.070 |
Why?
|
| Swine | 1 | 2011 | 1171 | 0.070 |
Why?
|
| CD18 Antigens | 2 | 1998 | 43 | 0.070 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 4426 | 0.070 |
Why?
|
| Antibody Specificity | 2 | 1998 | 196 | 0.070 |
Why?
|
| Recombinant Proteins | 3 | 2006 | 1293 | 0.060 |
Why?
|
| Drug Design | 1 | 2008 | 153 | 0.060 |
Why?
|
| Dendritic Cells | 2 | 2001 | 435 | 0.060 |
Why?
|
| Myocardium | 1 | 2011 | 847 | 0.060 |
Why?
|
| Cell Aggregation | 1 | 2006 | 19 | 0.060 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2006 | 116 | 0.060 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 2 | 2003 | 24 | 0.060 |
Why?
|
| Precipitin Tests | 2 | 2002 | 136 | 0.060 |
Why?
|
| Cells, Cultured | 4 | 2016 | 2893 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2002 | 678 | 0.060 |
Why?
|
| Mutagenesis | 1 | 2006 | 332 | 0.060 |
Why?
|
| Alternative Splicing | 1 | 2006 | 296 | 0.050 |
Why?
|
| Enzyme Activation | 2 | 2003 | 577 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 2 | 2003 | 985 | 0.050 |
Why?
|
| Cytokines | 2 | 2022 | 1317 | 0.050 |
Why?
|
| Phenylalanine | 1 | 2004 | 120 | 0.050 |
Why?
|
| Cell Surface Extensions | 1 | 2003 | 7 | 0.050 |
Why?
|
| Adenosine Diphosphate Ribose | 1 | 2003 | 7 | 0.050 |
Why?
|
| Microscopy, Video | 1 | 2003 | 19 | 0.050 |
Why?
|
| Cell Size | 1 | 2003 | 79 | 0.050 |
Why?
|
| Adjuvants, Pharmaceutic | 1 | 2022 | 13 | 0.050 |
Why?
|
| Ovalbumin | 1 | 2022 | 118 | 0.050 |
Why?
|
| Nickel | 1 | 2002 | 21 | 0.050 |
Why?
|
| Surface Plasmon Resonance | 1 | 2002 | 52 | 0.050 |
Why?
|
| Antigens | 1 | 2022 | 145 | 0.050 |
Why?
|
| Guanosine Triphosphate | 1 | 2002 | 38 | 0.050 |
Why?
|
| Ionomycin | 2 | 2000 | 15 | 0.050 |
Why?
|
| CTLA-4 Antigen | 1 | 2022 | 62 | 0.050 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 2000 | 59 | 0.050 |
Why?
|
| Contractile Proteins | 1 | 2001 | 16 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-vav | 1 | 2001 | 10 | 0.050 |
Why?
|
| Base Sequence | 1 | 2006 | 2756 | 0.050 |
Why?
|
| Integrin beta3 | 1 | 2001 | 27 | 0.050 |
Why?
|
| Glutathione Transferase | 1 | 2002 | 144 | 0.040 |
Why?
|
| Actin Cytoskeleton | 1 | 2001 | 48 | 0.040 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2022 | 130 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2002 | 622 | 0.040 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2022 | 133 | 0.040 |
Why?
|
| Reference Values | 2 | 1999 | 683 | 0.040 |
Why?
|
| Protein Kinase C | 1 | 2001 | 111 | 0.040 |
Why?
|
| Receptors, Lymphocyte Homing | 2 | 2000 | 17 | 0.040 |
Why?
|
| Adjuvants, Immunologic | 1 | 2022 | 380 | 0.040 |
Why?
|
| DNA | 1 | 2006 | 1419 | 0.040 |
Why?
|
| Amino Acids | 1 | 2022 | 615 | 0.040 |
Why?
|
| Microfilament Proteins | 1 | 2001 | 269 | 0.040 |
Why?
|
| Breast Neoplasms | 1 | 2012 | 2581 | 0.040 |
Why?
|
| Binding, Competitive | 2 | 1997 | 153 | 0.040 |
Why?
|
| Weightlessness | 1 | 2001 | 81 | 0.040 |
Why?
|
| Dose-Response Relationship, Immunologic | 2 | 1996 | 100 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2022 | 762 | 0.040 |
Why?
|
| Models, Genetic | 1 | 2002 | 742 | 0.040 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2022 | 439 | 0.040 |
Why?
|
| Cytoskeleton | 3 | 2009 | 167 | 0.040 |
Why?
|
| Immunity | 1 | 2019 | 175 | 0.040 |
Why?
|
| Biocompatible Materials | 1 | 2019 | 125 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2002 | 1595 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 1998 | 57 | 0.040 |
Why?
|
| Genetic Vectors | 1 | 2002 | 890 | 0.040 |
Why?
|
| Aspergillus fumigatus | 1 | 1998 | 43 | 0.040 |
Why?
|
| Interphase | 1 | 1998 | 35 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 1998 | 36 | 0.040 |
Why?
|
| Paxillin | 3 | 2003 | 11 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 1998 | 49 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2001 | 579 | 0.040 |
Why?
|
| Cyclosporine | 1 | 1998 | 126 | 0.030 |
Why?
|
| Cell Separation | 1 | 1998 | 219 | 0.030 |
Why?
|
| Tumor Microenvironment | 1 | 2022 | 628 | 0.030 |
Why?
|
| Apoptosis | 1 | 2024 | 1811 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2016 | 12537 | 0.030 |
Why?
|
| Amino Acid Substitution | 3 | 2003 | 398 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 3 | 2000 | 988 | 0.030 |
Why?
|
| Immunotherapy | 1 | 2022 | 740 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2000 | 588 | 0.030 |
Why?
|
| Lymphocytes | 1 | 1998 | 354 | 0.030 |
Why?
|
| Down-Regulation | 1 | 1998 | 646 | 0.030 |
Why?
|
| Iloprost | 1 | 2016 | 7 | 0.030 |
Why?
|
| Cyclooxygenase 1 | 1 | 2016 | 26 | 0.030 |
Why?
|
| Reperfusion | 1 | 2016 | 25 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 1998 | 336 | 0.030 |
Why?
|
| Running | 1 | 2016 | 32 | 0.030 |
Why?
|
| Muscles | 1 | 2016 | 222 | 0.030 |
Why?
|
| Transplantation, Heterologous | 1 | 2016 | 251 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2016 | 362 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2016 | 289 | 0.030 |
Why?
|
| Male | 1 | 2021 | 62490 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2016 | 568 | 0.030 |
Why?
|
| Vasodilator Agents | 1 | 2016 | 202 | 0.030 |
Why?
|
| Epitopes | 1 | 1996 | 418 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2016 | 767 | 0.030 |
Why?
|
| Integrin alpha5beta1 | 1 | 2013 | 4 | 0.030 |
Why?
|
| CD11a Antigen | 1 | 2013 | 11 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 1998 | 1377 | 0.030 |
Why?
|
| Chemokine CXCL12 | 1 | 2013 | 34 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2012 | 3497 | 0.030 |
Why?
|
| Motor Activity | 1 | 2016 | 504 | 0.020 |
Why?
|
| Oncogene Protein p21(ras) | 1 | 2012 | 11 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2016 | 1221 | 0.020 |
Why?
|
| Time Factors | 1 | 2002 | 6126 | 0.020 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2013 | 143 | 0.020 |
Why?
|
| Transfection | 2 | 2003 | 946 | 0.020 |
Why?
|
| Transcription Factors | 2 | 1999 | 2337 | 0.020 |
Why?
|
| Pulmonary Eosinophilia | 1 | 2010 | 8 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2012 | 302 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2012 | 634 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 1996 | 1204 | 0.020 |
Why?
|
| Chemotaxis | 1 | 2009 | 59 | 0.020 |
Why?
|
| Hypersensitivity | 1 | 2010 | 192 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2016 | 4502 | 0.020 |
Why?
|
| Flow Cytometry | 2 | 2000 | 754 | 0.020 |
Why?
|
| Mannosides | 1 | 2004 | 2 | 0.010 |
Why?
|
| Mannose | 1 | 2004 | 22 | 0.010 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2004 | 50 | 0.010 |
Why?
|
| Biphenyl Compounds | 1 | 2004 | 64 | 0.010 |
Why?
|
| Focal Adhesion Kinase 2 | 1 | 2003 | 7 | 0.010 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2003 | 23 | 0.010 |
Why?
|
| Receptor Cross-Talk | 1 | 2003 | 36 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2003 | 298 | 0.010 |
Why?
|
| Talin | 1 | 2001 | 11 | 0.010 |
Why?
|
| Isoleucine | 1 | 2001 | 25 | 0.010 |
Why?
|
| Focal Adhesions | 1 | 2001 | 14 | 0.010 |
Why?
|
| Filamins | 1 | 2001 | 27 | 0.010 |
Why?
|
| Receptors for Activated C Kinase | 1 | 2001 | 6 | 0.010 |
Why?
|
| Valine | 1 | 2001 | 110 | 0.010 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 2001 | 22 | 0.010 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 2001 | 53 | 0.010 |
Why?
|
| Cell Polarity | 1 | 2001 | 116 | 0.010 |
Why?
|
| Antigens, CD34 | 1 | 2001 | 99 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2003 | 449 | 0.010 |
Why?
|
| src-Family Kinases | 1 | 2001 | 90 | 0.010 |
Why?
|
| Interleukin-12 | 1 | 2001 | 119 | 0.010 |
Why?
|
| DNA-Binding Proteins | 2 | 1999 | 1877 | 0.010 |
Why?
|
| Fusion Regulatory Protein-1 | 1 | 2000 | 3 | 0.010 |
Why?
|
| Ionophores | 1 | 2000 | 9 | 0.010 |
Why?
|
| Microcomputers | 1 | 2000 | 12 | 0.010 |
Why?
|
| Molecular Mimicry | 1 | 1999 | 22 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2001 | 269 | 0.010 |
Why?
|
| Phagocytosis | 1 | 2001 | 191 | 0.010 |
Why?
|
| LIM Domain Proteins | 1 | 1999 | 65 | 0.010 |
Why?
|
| Tyrosine | 1 | 1999 | 146 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2003 | 756 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2004 | 1101 | 0.010 |
Why?
|
| Microscopy | 1 | 2000 | 121 | 0.010 |
Why?
|
| Phytohemagglutinins | 1 | 1998 | 10 | 0.010 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 1998 | 150 | 0.010 |
Why?
|
| Video Recording | 1 | 2000 | 200 | 0.010 |
Why?
|
| Immunomagnetic Separation | 1 | 1998 | 11 | 0.010 |
Why?
|
| Scattering, Radiation | 1 | 1998 | 48 | 0.010 |
Why?
|
| Light | 1 | 1998 | 165 | 0.010 |
Why?
|
| Muromonab-CD3 | 1 | 1996 | 7 | 0.010 |
Why?
|
| NFATC Transcription Factors | 1 | 1996 | 37 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 1998 | 792 | 0.010 |
Why?
|
| NF-kappa B | 1 | 1996 | 438 | 0.010 |
Why?
|
| Phenotype | 1 | 1998 | 4302 | 0.000 |
Why?
|
| Female | 1 | 2012 | 68275 | 0.000 |
Why?
|